Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck

E-ISSN： 1097-0347|37|2|182-187

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.2, 2015-02, pp. : 182-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma

THE LARYNGOSCOPE, Vol. 125, Iss. 9, 2015-09 ,pp. : E292-E299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 5, 2015-05 ,pp. : 722-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined intensity‐modulated radiotherapy plus raster‐scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 3001-3009

John Wiley & Sons Inc

Access to resources Recommend Favorite

International collaborative validation of intraneural invasion as a prognostic marker in adenoid cystic carcinoma of the head and neck

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 7, 2015-07 ,pp. : 1038-1045

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 66-71

Karger

Access to resources Recommend Favorite